Jylamvo Solution
Product Images NDC 81927-204

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Jylamvo (NDC 81927-204). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Shorla Oncology Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Carton001)

Principal Display Panel (Carton001)
This is a description of a medication called JYLAMVO, which is an oral solution containing 2mg of methotrexate per mL. The recommended dosage and other important information can be found in the Prescribing Information. Each pack of JYLAMVO includes a bottle of medicine with a cap, a bottle adaptor, and a white dosing syringe. It is important to always use the provided syringe to take the medicine. The medication should be stored at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). The expiry date of the medication includes up to 3 months after the first opening, and any unused portion should be discarded. The medication is manufactured by SGS Quay Pharmacouicas Ltd. and distributed by Shoria Oneology Inc. The NDC number is 81927-20401. This medication should only be used as directed by a pharmacist, who will provide patient information to each individual receiving the medication.*
FDA Label Image

Principal Display Panel (Label001)

FDA Label Image

Structural Formula (Methotrexate Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.